Skip to content

Acute Kidney Injury in Patients Hospitalized With COVID-19

Acute Kidney Injury in Patients Hospitalized With COVID-19 in Wuhan, China: a Single-center Retrospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04316299
Enrollment
287
Registered
2020-03-20
Start date
2020-02-26
Completion date
2020-03-08
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, COVID-19, Kidney Function

Brief summary

The kidney may be affected in coronavirus-2019 disease (COVID-19). This study assessed the predictors and outcomes of acute kidney injury (AKI) among individuals with COVID-19.

Interventions

None listed

Sponsors

Zhenhua Zen
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COVID-19 pneumonia patients diagnosed by WHO criteria

Exclusion criteria

* Patients who were younger than 18 years, * Patients who had undergone renal replacement therapy (RRT) before admission, * Patients whose entire stay lasted for less than 48 hours.

Design outcomes

Primary

MeasureTime frameDescription
Rate of Acute Kidney InjuryFrom date of admission until the date of discharge or death from any cause, up to 60 daysthe incidence of Acute Kidney Injury

Secondary

MeasureTime frameDescription
the length of hospital stayFrom date of admission until the date of discharge or death from any cause, up to 60 daysdays from admission to discharge or death
Rate of DeathFrom date of admission until the date of death from any cause, up to 60 daysdeath from any cause in the hospital

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026